Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    17898352 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Acute Glycine Pharmacodynamic Study
Conditions: Schizophrenia;   Psychotic Disorders
Intervention: Dietary Supplement: Glycine administration
2 Enrolling by invitation Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
Conditions: Schizophrenia;   Bipolar Disorder
Interventions: Drug: D-cycloserine;   Drug: placebo
3 Enrolling by invitation Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
Conditions: Schizo-affective Disorder;   Bipolar Disorder
Interventions: Drug: glycine powder;   Drug: placebo
4 Completed Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: d-cycloserine;   Drug: glycine;   Drug: placebo

Indicates status has not been verified in more than two years